{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-1992-N-0049\" sorted by posted_date descending", "rows": [["FDA-1992-N-0049-0034", "FDA", "FDA-1992-N-0049", "Reference 12 - \"Comment No. LET20, 1981N-0114\" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-03-08T05:00:00Z", 2010, 3, null, null, "2010-03-08T06:40:41Z", null, 0, 0, "0900006480ab4d30"], ["FDA-1992-N-0049-0031", "FDA", "FDA-1992-N-0049", "Reference 5 - \"International Conference On Harmonisation of Technical Requirements For Registration of Pharmaceuticals For Human Use\" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-03-08T05:00:00Z", 2010, 3, null, null, "2010-03-08T06:40:36Z", null, 0, 0, "0900006480ab48e8"], ["FDA-1992-N-0049-0033", "FDA", "FDA-1992-N-0049", "Reference 11 - \"Comment No. LET19, 1981N-0114\" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-03-08T05:00:00Z", 2010, 3, null, null, "2010-03-08T06:40:39Z", null, 0, 0, "0900006480ab4d2e"], ["FDA-1992-N-0049-0035", "FDA", "FDA-1992-N-0049", "Reference 13 - \"Comment No. LET21, 1981N-0114\" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-03-08T05:00:00Z", 2010, 3, null, null, "2010-03-08T06:40:42Z", null, 0, 0, "0900006480ab4d32"], ["FDA-1992-N-0049-0042", "FDA", "FDA-1992-N-0049", "Reference 22 - \"FDA Labeling Cost Model, Final Report\" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-03-08T05:00:00Z", 2010, 3, null, null, "2010-03-08T06:40:53Z", null, 0, 0, "0900006480ab4eaa"], ["FDA-1992-N-0049-0039", "FDA", "FDA-1992-N-0049", "Reference 17 - \"Comment No. C4, NDMA 1992N-0311\" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-03-08T05:00:00Z", 2010, 3, null, null, "2010-03-08T06:40:48Z", null, 0, 0, "0900006480ab4d3e"], ["FDA-1992-N-0049-0036", "FDA", "FDA-1992-N-0049", "Reference 14 - \"Comment No. LET22, 1981N-0114\" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-03-08T05:00:00Z", 2010, 3, null, null, "2010-03-08T06:40:44Z", null, 0, 0, "0900006480ab4d3b"], ["FDA-1992-N-0049-0032", "FDA", "FDA-1992-N-0049", "Reference 10 - \"Comment No. RPT3, 1981N-0114\" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-03-08T05:00:00Z", 2010, 3, null, null, "2010-03-08T06:40:38Z", null, 0, 0, "0900006480ab4d2c"], ["FDA-1992-N-0049-0040", "FDA", "FDA-1992-N-0049", "Reference 18 - \"Comment No. C1, Target Health Inc., 1992N-0311\" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-03-08T05:00:00Z", 2010, 3, null, null, "2010-03-08T06:40:50Z", null, 0, 0, "0900006480ab4d3f"], ["FDA-1992-N-0049-0029", "FDA", "FDA-1992-N-0049", "List of References - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-03-08T05:00:00Z", 2010, 3, null, null, "2010-03-08T06:40:33Z", null, 0, 0, "0900006480ab488e"], ["FDA-1992-N-0049-0037", "FDA", "FDA-1992-N-0049", "Reference 15 - \"Comment No. RPT4, 1981N-0114\" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-03-08T05:00:00Z", 2010, 3, null, null, "2010-03-08T06:40:45Z", null, 0, 0, "0900006480ab4d3c"], ["FDA-1992-N-0049-0030", "FDA", "FDA-1992-N-0049", "Reference 3 - \"Comment No. C4, 1981N-114A\" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-03-08T05:00:00Z", 2010, 3, null, null, "2010-03-08T06:40:35Z", null, 0, 0, "0900006480ab48e5"], ["FDA-1992-N-0049-0041", "FDA", "FDA-1992-N-0049", "Reference 21 - \"Comment No. C2, Wholesale Druggists' Association, 1992N-0311\" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-03-08T05:00:00Z", 2010, 3, null, null, "2010-03-08T06:40:51Z", null, 0, 0, "0900006480ab4ea5"], ["FDA-1992-N-0049-0038", "FDA", "FDA-1992-N-0049", "Reference 16 - \"Comment No. C3, American Academy of Dermatology\" - [Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule]", "Supporting & Related Material", "BKG-Background Material", "2010-03-08T05:00:00Z", 2010, 3, null, null, "2010-03-08T06:40:47Z", null, 0, 0, "0900006480ab4d3d"], ["FDA-1992-N-0049-0028", "FDA", "FDA-1992-N-0049", "Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-the-Counter Human Use; Final Rule", "Rule", "NFR-Notice of Final Rule", "2010-03-04T05:00:00Z", 2010, 3, "2010-03-04T05:00:00Z", null, "2010-03-08T06:09:32Z", null, 0, 0, "0900006480ab4f84"], ["FDA-1992-N-0049-0023", "FDA", "FDA-1992-N-0049", "NDMA (Nonprescription Drug Manufacturers Association - Request for Extension of Comment Due Date", "Other", "EXT-Request for Extension Comment Due Date", "2010-02-25T05:00:00Z", 2010, 2, "2010-02-25T05:00:00Z", null, "2013-07-27T21:29:03Z", null, 0, 0, "090000648052bd03"], ["FDA-1992-N-0049-0002", "FDA", "FDA-1992-N-0049", "Topical Drug Products Containing Benzoyl Peroxide; Required Labeling; Extension of Comment Period", "Notice", "NEC-Notice of Extension", "1995-06-07T04:00:00Z", 1995, 6, "1995-06-07T04:00:00Z", "1995-07-18T03:59:59Z", "2010-02-25T18:34:06Z", null, 0, 0, "090000648052bd0a"], ["FDA-1992-N-0049-0001", "FDA", "FDA-1992-N-0049", "Topical Drug Products Containing Benzoyl Peroxide; Required Labeling", "Proposed Rule", "NPR-Notice of Proposed Rule-Making", "1995-02-23T05:00:00Z", 1995, 2, "1995-02-23T05:00:00Z", "1995-05-19T03:59:59Z", "2010-02-25T18:30:48Z", null, 0, 0, "090000648052bcf4"], ["FDA-1992-N-0049-0022", "FDA", "FDA-1992-N-0049", "Reference 13 - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling]   - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling]", "Supporting & Related Material", "BKG-Background Material", "1995-02-17T05:00:00Z", 1995, 2, null, null, "2010-02-25T21:11:46Z", null, 0, 0, "090000648052bd26"], ["FDA-1992-N-0049-0004", "FDA", "FDA-1992-N-0049", "Background Material", "Supporting & Related Material", "BKG-Background Material", "1995-02-17T05:00:00Z", 1995, 2, null, null, "2008-05-16T23:34:17Z", null, 0, 0, "090000648052bd0e"], ["FDA-1992-N-0049-0009", "FDA", "FDA-1992-N-0049", "Reference 2 - \"Kurokawa, et al., Studies on the Promoting and Complete Carcinogenic Activities of Some Oxidizing Chemicals in Skin Carcinogensis\" - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling]", "Supporting & Related Material", "BKG-Background Material", "1995-02-17T05:00:00Z", 1995, 2, null, null, "2010-02-25T20:47:08Z", null, 0, 0, "090000648052bd19"], ["FDA-1992-N-0049-0010", "FDA", "FDA-1992-N-0049", "Reference 3 - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling]", "Supporting & Related Material", "BKG-Background Material", "1995-02-17T05:00:00Z", 1995, 2, null, null, "2010-02-25T21:06:34Z", null, 0, 0, "090000648052bd1a"], ["FDA-1992-N-0049-0008", "FDA", "FDA-1992-N-0049", "Reference 1 - \"Slaga, et al., Skin Tumor-Promoting Activity of Benzoyl Peroxide, a Widely Used Free Radical-Generating Compound\" - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling]", "Supporting & Related Material", "BKG-Background Material", "1995-02-17T05:00:00Z", 1995, 2, null, null, "2010-02-25T20:42:29Z", null, 0, 0, "090000648052bd18"], ["FDA-1992-N-0049-0007", "FDA", "FDA-1992-N-0049", "FDA Memorandum to Dockets Management Branch, February 22, 1995, Public Administrative File for Proposal Rule - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling]", "Supporting & Related Material", "BKG-Background Material", "1995-02-17T05:00:00Z", 1995, 2, null, null, "2010-02-25T20:36:08Z", null, 0, 0, "090000648052bd17"], ["FDA-1992-N-0049-0018", "FDA", "FDA-1992-N-0049", "Background Material", "Supporting & Related Material", "BKG-Background Material", "1995-02-17T05:00:00Z", 1995, 2, null, null, "2008-05-16T23:34:17Z", null, 0, 0, "090000648052bd22"], ["FDA-1992-N-0049-0013", "FDA", "FDA-1992-N-0049", "Reference 1.2 - \"Correspondence and Memoranda\" - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling]", "Supporting & Related Material", "BKG-Background Material", "1995-02-17T05:00:00Z", 1995, 2, null, null, "2010-02-25T20:55:48Z", null, 0, 0, "090000648052bd1d"], ["FDA-1992-N-0049-0017", "FDA", "FDA-1992-N-0049", "Background Material", "Supporting & Related Material", "BKG-Background Material", "1995-02-17T05:00:00Z", 1995, 2, null, null, "2008-05-16T23:34:17Z", null, 0, 0, "090000648052bd21"], ["FDA-1992-N-0049-0005", "FDA", "FDA-1992-N-0049", "Reference 10 - \"Iversen, Carcinogenesis Studies with Benzoyl- Peroxide\" - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling]", "Supporting & Related Material", "BKG-Background Material", "1995-02-17T05:00:00Z", 1995, 2, null, null, "2010-02-25T20:13:37Z", null, 0, 0, "090000648052bd12"], ["FDA-1992-N-0049-0012", "FDA", "FDA-1992-N-0049", "Reference 17 - \"Physicians' Desk Reference, 47th Edition\" - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling]", "Supporting & Related Material", "BKG-Background Material", "1995-02-17T05:00:00Z", 1995, 2, null, null, "2010-02-25T20:53:18Z", null, 0, 0, "090000648052bd1c"], ["FDA-1992-N-0049-0015", "FDA", "FDA-1992-N-0049", "Background Material", "Supporting & Related Material", "BKG-Background Material", "1995-02-17T05:00:00Z", 1995, 2, null, null, "2008-05-16T23:34:17Z", null, 0, 0, "090000648052bd1f"], ["FDA-1992-N-0049-0011", "FDA", "FDA-1992-N-0049", "Reference 16 - \"Hogan, et al., Studies on the Promoting and Complete Carcinogenic Activities of Some Oxidizing Chemicals in Skin Carcinogensis\" - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling]", "Supporting & Related Material", "BKG-Background Material", "1995-02-17T05:00:00Z", 1995, 2, null, null, "2010-02-25T20:51:17Z", null, 0, 0, "090000648052bd1b"], ["FDA-1992-N-0049-0003", "FDA", "FDA-1992-N-0049", "Background Material", "Supporting & Related Material", "BKG-Background Material", "1995-02-17T05:00:00Z", 1995, 2, null, null, "2008-05-16T23:34:17Z", null, 0, 0, "090000648052bd0c"], ["FDA-1992-N-0049-0016", "FDA", "FDA-1992-N-0049", "Background Material", "Supporting & Related Material", "BKG-Background Material", "1995-02-17T05:00:00Z", 1995, 2, null, null, "2008-05-16T23:34:17Z", null, 0, 0, "090000648052bd20"], ["FDA-1992-N-0049-0014", "FDA", "FDA-1992-N-0049", "Reference 7 - \"Comments C31, PR1, & PR2\" - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling]", "Supporting & Related Material", "BKG-Background Material", "1995-02-17T05:00:00Z", 1995, 2, null, null, "2010-02-25T20:59:44Z", null, 0, 0, "090000648052bd1e"], ["FDA-1992-N-0049-0020", "FDA", "FDA-1992-N-0049", "Background Material", "Supporting & Related Material", "BKG-Background Material", "1995-02-17T05:00:00Z", 1995, 2, null, null, "2008-05-16T23:34:17Z", null, 0, 0, "090000648052bd24"], ["FDA-1992-N-0049-0021", "FDA", "FDA-1992-N-0049", "Background Material", "Supporting & Related Material", "BKG-Background Material", "1995-02-17T05:00:00Z", 1995, 2, null, null, "2008-05-16T23:34:17Z", null, 0, 0, "090000648052bd25"], ["FDA-1992-N-0049-0019", "FDA", "FDA-1992-N-0049", "Background Material", "Supporting & Related Material", "BKG-Background Material", "1995-02-17T05:00:00Z", 1995, 2, null, null, "2008-05-16T23:34:17Z", null, 0, 0, "090000648052bd23"], ["FDA-1992-N-0049-0006", "FDA", "FDA-1992-N-0049", "Reference 11 - \"Iversen, Skin Tumorigenesis and Carcinogenesis Studies With7,12-Dimethylbenz[a]anthracene, Ultraviolet Light, Benzoyl Peroxide (Panoxyl gel 5%) and Ointment Gel \" - [Topical Drug Products Containing Benzoyl Peroxide; Required Labeling]", "Supporting & Related Material", "BKG-Background Material", "1995-02-17T05:00:00Z", 1995, 2, null, null, "2010-02-25T20:24:04Z", null, 0, 0, "090000648052bd14"]], "truncated": false, "filtered_table_rows_count": 38, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-1992-N-0049"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049", "results": [{"value": "FDA", "label": "FDA", "count": 38, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1992-N-0049", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 34, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049&document_type=Notice", "selected": false}, {"value": "Other", "label": "Other", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049&document_type=Other", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049&document_type=Proposed+Rule", "selected": false}, {"value": "Rule", "label": "Rule", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049&document_type=Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049", "results": [{"value": 1995, "label": 1995, "count": 22, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049&posted_year=1995", "selected": false}, {"value": 2010, "label": 2010, "count": 16, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049&posted_year=2010", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "title", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049&_facet=title"}, {"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049&_facet=posted_month"}, {"name": "last_modified", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049&_facet=last_modified"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1992-N-0049&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 1321.327774785459, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}